Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the antisialagogues (anti-salivary agents),
Atropine and Glycopyrrolate, are effective in reducing hypersalivation when sedating patients
with Ketamine for procedural sedation in the emergency department or abscess clinic. The
investigators will measure salivary flow rate by collecting oral secretions by oral
suctioning over a 30 minute time period starting with the administration of Ketamine. The
investigators hypothesize that patients who receive either atropine or glycopyrrolate will
have fewer oral secretions than patients who receive placebo.